Currently, leptin, resistin, and visfatin are the most widely used pro-inflammatory adipokines in experimental studies, as well as in clinical trials of anti-diabetic preparations and other therapeutics targeting obesity-associated diseases. The gene discussed is RETN; the disease is obesity due to melanocortin 4 receptor deficiency.